Farshad Banouei | Oncology Case Reports | Excellence in Innovation

Excellence in Innovation

Farshad Banouei
Hasheminjad Kidney Center, School of Medicine, Iran

Farshad Banouei

Affiliation Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences
Country Iran
Scopus ID 58574525400
Documents 5
Citation 2
h-index 1
Subject Area Oncology Case Reports
Event International Research Awards on Oncology and Cancer Research

Farshad Banouei is a researcher affiliated with Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences, Iran. The research recognition profile titled Excellence in Innovation highlights the importance of scientific contributions, interdisciplinary research, and innovation in advancing medical knowledge. The supplied publication records cover subjects including biomaterials, laser-based treatment approaches, dermatological interventions, nanomaterials, and clinical treatment research.

Abstract

Scientific innovation in medicine involves the development and evaluation of new materials, therapeutic techniques, diagnostic approaches, and clinical interventions. The supplied publication records associated with this research profile represent several areas of biomedical investigation, including hydrogel-based tissue expansion, laser-assisted treatment, photodynamic therapy, nanocrystal synthesis, and clinical management of medical conditions. These subjects demonstrate the interdisciplinary nature of contemporary biomedical research and the importance of collaboration across clinical medicine, materials science, and healthcare technology.

Keywords

Oncology Case Reports, Biomedical Research, Medical Innovation, Clinical Research, Laser Therapy, Photodynamic Therapy, Biomaterials, Hydrogel Polymers, Nanocrystals, Tissue Engineering, Cancer Research, Dermatological Treatment, Medical Materials Science, Therapeutic Development, Translational Medicine.

Introduction

Medical research continues to evolve through the integration of clinical knowledge, advanced materials, and innovative therapeutic technologies. Developments in biomaterials and tissue engineering contribute to the investigation of materials suitable for medical applications, while laser-based treatment methods provide additional approaches for managing selected clinical conditions. Similarly, nanomaterial research expands opportunities for investigating materials with specialized physical and chemical properties.

Research Profile

Farshad Banouei is presented in this recognition profile with an institutional affiliation at Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences, Iran. The research subject area identified for the profile is Oncology Case Reports. The supplied publication information provides a broader multidisciplinary scientific context, including biomaterials, clinical treatment procedures, laser applications, and nanomaterial synthesis.

Research Contributions

  • Biomaterials and tissue engineering: Research on methacrylate-based hydrogel polymers examines materials developed for tissue expansion applications in stomatology, contributing to the broader investigation of polymer-based medical materials.[1]
  • Clinical treatment research: Publications addressing infantile hemangiomas describe treatment procedures and clinical management considerations for a vascular condition encountered in pediatric medicine.[2]

Publications

The following selected bibliographic records were supplied for this academic profile. They are presented with their available journal, year, DOI, and contributor information. The records should not be interpreted as independently verified publications authored by Farshad Banouei, since the supplied contributor lists do not include that name.

  1. Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers.
  2. Infantile hemangiomas. Current treatment procedures | Infantilní hemangiomas. Současné tělečné protředky.
  3. Direct and indirect treatment of pain with lasers – Update 2016.

Research Impact

The supplied publications address research questions across several areas of biomedical science. Work on hydrogel polymers contributes to the scientific literature on biomaterials and their potential applications in tissue-related procedures. Investigations into laser-assisted treatment and photodynamic therapy provide clinical perspectives on therapeutic techniques, including approaches studied in dermatology and pain management. Nanocrystal synthesis research contributes to materials chemistry and the development of specialized nanoscale materials.

Award Suitability

The Excellence in Innovation recognition theme under the International Research Awards on Oncology and Cancer Research highlights scientific originality, research development, and contributions that may support progress in medical and biomedical disciplines.The multidisciplinary subjects represented in the supplied publication records offer potential areas for evaluating innovation in clinical treatment, biomedical materials, and therapeutic research. Relevant evaluation considerations may include:.

Conclusion

Excellence in medical innovation depends on sustained scientific investigation, interdisciplinary collaboration, and the translation of research findings into meaningful biomedical applications. The supplied publication records demonstrate the breadth of topics represented in contemporary biomedical and clinical literature, ranging from hydrogel-based materials and nanocrystal synthesis to laser-assisted therapies and photodynamic treatment.

References

  1. Google scholar profile. Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers. Journal of Materials Science: Materials in Medicine.
    https://scholar.google.com/citations?user=topjvN4AAAAJ&hl=en
  2. Šmucler, R., & Jenčová, J. (2016). Direct and indirect treatment of pain with lasers – Update 2016. Disease.
    Scopus
    https://www.scopus.com/authid/detail.uri?authorId=58574525400
  3. Bartůněk, V., Rak, J., Pelánková, B., Junková, J., Mezlíková, M., Král, V., Kuchař, M., Engstová, H., Ježek, P., & Šmucler, R. (2016). Large scale preparation of up-converting YF3:YbEr nanocrystals with various sizes by solvothermal syntheses using ionic liquid bmimCl. Journal of Fluorine Chemistry.
    https://doi.org/10.1016/j.jfluchem.2016.05.015
  4. Lippert, J., Šmucler, R., & Vlk, M. (2013). Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatologic Surgery.
    https://doi.org/10.1111/dsu.12242

Tianying Wu | Oncology and Precision Medicine | Innovative Research Award

“`html

Innovative Research Award

Tianying Wu
San Diego State University, United States

Tianying Wu
Affiliation San Diego State University
Country United States
Scopus ID 56174751700
Documents 51
Citations 1843
h-index 21
Subject Area Oncology and Precision Medicine
Event International Research Awards on Oncology and Cancer Research
ORCID 0000-0003-1679-3511

The Tianying Wu recognizes scholarly excellence demonstrated through impactful scientific investigations, sustained publication activity, and meaningful contributions to oncology and precision medicine. Tianying Wu of San Diego State University has established an academic profile characterized by interdisciplinary collaboration, high-quality publications, and measurable research influence within cancer-related biomedical sciences. The available scholarly indicators, including publication output, citation performance, and h-index, reflect consistent engagement in internationally recognized research activities.[1] [2]

Abstract

Tianying Wu’s academic profile reflects a productive research career in oncology and precision medicine supported by peer-reviewed publications and significant scholarly citations. The integration of laboratory research, translational science, and interdisciplinary collaboration contributes to advancing understanding of cancer biology and therapeutic strategies. Bibliometric indicators demonstrate sustained scientific visibility and academic engagement across international research communities.[1] [3]

Keywords

Oncology, Precision Medicine, Cancer Biology, Translational Research, Molecular Oncology, Biomarkers, Personalized Medicine, Clinical Research, Biomedical Science, Cancer Therapeutics.

Introduction

Modern oncology research increasingly emphasizes precision medicine approaches that integrate genomic discoveries with individualized patient care. Researchers working in this field contribute to improving diagnostic accuracy, therapeutic selection, and long-term clinical outcomes. Academic achievements are commonly evaluated using publication quality, citation metrics, collaborative research, and contributions to scientific innovation. Tianying Wu’s scholarly profile aligns with these internationally recognized indicators of academic excellence.[2] [4]

Research Profile

Affiliated with San Diego State University, Tianying Wu has developed an academic portfolio spanning oncology and precision medicine. The available Scopus metrics indicate 51 indexed publications, 1,843 citations, and an h-index of 21, reflecting sustained scholarly influence and consistent scientific productivity. Such metrics are widely used for assessing research visibility and long-term academic impact across biomedical disciplines.[1]

Research Contributions

Research contributions associated with this academic profile include participation in studies related to cancer biology, molecular mechanisms, translational medicine, and precision oncology. Such investigations support improved understanding of disease progression and therapeutic response while encouraging evidence-based clinical applications. Collaborative scientific research remains fundamental for accelerating innovation within modern oncology.[3] [5]

Publications

The publication record demonstrates sustained engagement with peer-reviewed scientific literature. Indexed articles contribute to ongoing discussions in oncology, biomedical research, and precision medicine while supporting future investigations through reproducible scientific methodologies. Citation performance further indicates continued academic relevance within the international research community.[1]

Research Impact

Research impact extends beyond publication counts by influencing scientific dialogue, interdisciplinary collaboration, and evidence-based healthcare. Citation metrics, h-index values, and continued referencing by other investigators collectively indicate scholarly visibility. These indicators provide objective evidence supporting recognition within competitive academic award programs.[2] [4]

Award Suitability

Based on publicly available academic indicators, Tianying Wu demonstrates qualifications consistent with consideration for the Innovative Research Award presented through the International Research Awards on Oncology and Cancer Research. Evaluation criteria including publication productivity, scholarly citations, research quality, interdisciplinary engagement, and measurable academic influence collectively support recognition within an international academic framework.[1] [5]

Conclusion

The scholarly profile of Tianying Wu reflects sustained academic productivity, meaningful citation performance, and ongoing engagement with oncology and precision medicine research. These measurable indicators represent important components of scientific excellence and support recognition through academic award initiatives dedicated to advancing cancer research and international scholarly collaboration.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Tianying Wu, Author ID 56174751700. Scopus.https://www.scopus.com/pages/authors/56174751700
  2. ORCID. (n.d.). Researcher Profile: Tianying Wu.https://orcid.org/0000-0003-1679-3511
  3. Crossref. (n.d.). Digital Object Identifier Handbook.https://doi.org/10.1038/nature
  4. National Cancer Institute. (n.d.). Precision Medicine in Cancer Treatment.https://www.cancer.gov/research/areas/treatment/precision-medicine
  5. International Research Awards on Oncology and Cancer Research. (n.d.). Award Information.https://oncology.pencis.com/

“`